MEIP - MEI Pharma promotes Richard Ghalie to chief medical officer

MEI Pharma (MEIP) announces that Richard Ghalie, senior vice president, clinical development, has been promoted as the company's chief medical officer.The company also announces that its current chief medical officer Robert Mass will retire on May 3, 2021.Ghalie is a hematologist and oncologist with more than 25 years of drug development experience at public and private companies, and has held several executive positions in the pharmaceutical industry.Shares down nearly 2% premarket.

For further details see:

MEI Pharma promotes Richard Ghalie to chief medical officer